Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousRequests for Continued Examination Continue to Rise
By Dennis Crouch
The chart above shows Requests for Continued Examination (and the earlier CPA/R129 processes) as a percentage of the total number of non-provisional patent applications filed each year.
Notes: The denominator here does not include RCE filings but does include continuations and CIP filings. Thus, the calculation is: (Number of RCEs)/(Number of Non-Provisional Filing). The denominator does include plant & reissue applications, but those numbers are negligible.
Full post as published by Patently Obvious on July 08, 2010 (boomark / email).
Bunk Beds
Injuries on the rise
FDA
Requests Labeling Change for Singulair, Accolate and Zyflo and Zyflo CR
Bush Administration
class action settlement ensures Medicaid beneficiaries can continue to purchase prescription drugs at minimum cost when they become eligible for Medicare.
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Some Comments on RCEs, Submissions, and RCE Strategy
COMMERCIAL DELINQUENCIES RISE AGAIN, DATA GOES IGNORED
Examples of Strategic Uses of Requests for Continued Examination (RCEs)








